Steve Closter
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steve Closter
The proxy statement of Syndax Pharmaceuticals Inc reports total compensation of $2,125,887 for Steve Closter in fiscal 2025, including a base salary of $485,300. Disclosed compensation is on record for 2 fiscal years. Steve Closter has spoken on 2 earnings calls across 1 company, most recently for Syndax Pharmaceuticals Inc on August 4, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Syndax Pharmaceuticals Inc (SNDX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Syndax Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Michael A. Metzger CEO, Board Member
- Michael Metzger CEO
- Daphne Karydas CFO
- Keith A. Goldan CFO
- Keith Goldan CFO
- Luke J. Albrecht General Counsel
- Aleksandra Rizo, M.D., Ph.D. Board Member
- Martin H. Huber, M.D. Board Member
- Pierre Legault Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Syndax Pharmaceuticals Inc (SNDX) | Chief Commercial Officer | $485,300 | $2,125,887 |
| 2024 | Syndax Pharmaceuticals Inc (SNDX) | Chief Commercial Officer | $364,167 | $3,557,137 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.